"10.1371_journal.pone.0030118","plos one","2012-02-15T00:00:00Z","Max Lataillade; Jennifer Chiarella; Rong Yang; Michelle DeGrosky; Jonathan Uy; Daniel Seekins; Birgitte Simen; Elizabeth St. John; Elizabeth Moreno; Michael Kozal","Research and Development, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America; Yale University School of Medicine and Veterans Affairs Health Care Systems, New Haven, Connecticut, United States of America; Research and Development, Bristol-Myers Squibb, Plainsboro, New Jersey, United States of America; 454 Life Sciences-Roche Co., Branford, Connecticut, United States of America","Conceived and designed the experiments: ML MK. Performed the experiments: JC ML MK ESJ EM. Analyzed the data: ML MK JC RY BS. Contributed reagents/materials/analysis tools: MDG JU DS RY. Wrote the paper: ML MK JC. Manuscript review: JC JU DS RY.","The authors have read the journals policy and have the following conflicts: Max Lataillade, Rong Yang, Michelle DeGrosky, Daniel Seekins, Jonathan Uy, and Donnie McGrath are employees of Bristol Myers Squibb, who funded this study. Yale University receives grant support from Merck, Pfizer, Gilead, Abbott and Bristol-Myers Squibb for studies that MJK serves as the principal investigator. Michael J. Kozal receives royalties from a patent owned by Stanford University for some HIV diagnostic tests. Elizabeth P. St. John and Birgitte B. Simen are employees of 454 Life Sciences-Roche Co. There are no products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials. The four patent numbers are: 5,631,128; 5,650,268; 5,856,086; and US RE38,352E.","2012","02","Max Lataillade","ML",10,TRUE,2,5,5,3,TRUE,TRUE,FALSE,0,NA,FALSE
